Wikipedia -WSS

Wikipedia

author：focus 2025-10-01 01:50:21 - browse：71412

Adam's take main illustration — Molly Ferguson/STAT

Have you heard the news? I’m launching a weekly email newsletter starting on March 28. It’s called Adam’s Biotech Scorecard and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

This week: A chat with Argenx CEO Tim Van Hauwermeiren, and updates on biotech PIPEs, Madrigal Pharmaceuticals, and Annovis Bio.

The Belgian drugmaker Argenx is preparing for a commercial launch this summer that will expand the use of its IgG-lowering antibody Vyvgart to patients with chronic inflammatory demyelinating polyneuropathy, or CIDP, an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Chemotherapy shortages won’t get better under Biden’s latest plan

WSS

Biden report: The neurospychology of memory and aging

Medical mystery: When a cough is not just a cough

What we’ve learned from the Aduhelm mess

For Medicare Advantage, Democrats want stronger protections around AI

Chemotherapy shortages won’t get better under Biden’s latest plan

Leukemia patients are helped by Syndax's new type of therapy

focus

Wikipedia

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

Key House Republican on health care plans exit from Congress

Heart attack and stroke risk calculators need revising

Why sickle cell disease is getting the first CRISPR treatment

Anesthesiologist group: stop taking Ozempic before surgery

PhRMA lawsuit over Medicare drug price negotiation tossed

In age of alternative facts, a scholarly course on calling out crap

Congenital heart disease patients face new threat of heart failure

State Dept. review finds Biden bears some blame for Afghanistan failures

How digital tools helped lower hypertension in marginalized patients

focus

Industry veterans launch new biotech VC with $310M

What should King Charles tell the public about his cancer?

CMS should re

Gilead might be held responsible for not developing a drug

Vaccine advisory panel ACIP left half staffed by HHS

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

focus

Wikipedia

focus

hotspot